Although this outcome may seem odd, given the tumor suppressor capabilities of this gene, a similar phenomenon was earlier observed in small-cell lung cancer [30], where the authors of the cited research reported a link between the occurrence of BRCA2 mutations and the higher sensitivity of tumors to chemotherapy. This evidence concerns the gene BRCA2 and neoplasm.